← Back to Research Radar
Academic Publication Academic Publication

Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer

179
Citations
January 1, 2025
Published Date

Research Abstract & Technology Focus

No abstract provided for this literature.
Read Full Literature

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

crossref.org › academic paper
73%
🔥

Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer

No description provided.

crossref.org › academic paper
0%

Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer

Abstract Understanding the role of the tumor microenvironment (TME) in lung cancer is critical to improving patient outcomes. We identifi...

roipad.com › trend story
0%

Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-Seq

Single-cell transcriptomics has improved the characterisation of pre-clinical tumour models. Here, the authors present a method to distinguish vascular from intratissue cells for single-cell transc...

crossref.org › academic paper
0%

iMLGAM: Integrated Machine Learning and Genetic Algorithm‐driven Multiomics analysis for pan‐cancer immunotherapy response prediction

AbstractTo address the substantial variability in immune checkpoint blockade (ICB) therapy effectiveness, we developed an innovative R package called integrated Machine Learning and Genetic Algorit...

roipad.com › trend story
0%

Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer

While small cell lung cancer (SCLC) typically responds well to chemotherapy, resistance often develops rapidly with limited therapeutic options. Here, using an in vivo CRISPR deletion screen in pat...

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer'?

This literature focuses on:

Which startups are commercializing the technology behind Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer?

Products like Glasp MCP Connector are bringing this to market. Their focus is: Search your highlights and notes inside Claude and ChatGPT.

What other academic literature is closely related to 'Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer'?

Yes, highly correlated activity was mapped. An entry titled 'Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer' discusses this: No description provided.

Are there commercial applications of 'Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer' in market news publications?

Yes, highly correlated activity was mapped. An entry titled 'Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-Seq' discusses this: Single-cell transcriptomics has improved the characterisation of pre-clinical tumour models. Here, the authors present a method to distinguish vasc...

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.

Commercial Realization

Startups and Open Source tools heavily associated with the concepts explored in this paper.

Associated Media Narrative